SEC Form 4 · accession 0001214659-15-007701
IMAX CORP · IMAX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard L Gelfond
Officer — Chief Executive Officer · Director
Period of report
Nov 9, 2015
Accepted (ET)
Nov 12, 2015 · 4:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921582
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| common sharesF1 | Nov 9, 2015 | C | 33,333 | $18.38 | A | 156,926 | D | |
| common sharesF1 | Nov 9, 2015 | S | 33,333 | $39.2385 | D | 123,593 | D | |
| common sharesF1 | Nov 10, 2015 | C | 33,333 | $18.38 | A | 156,926 | D | |
| common sharesF1 | Nov 10, 2015 | S | 33,333 | $39.2726 | D | 123,593 | D | |
| common sharesF1 | Nov 11, 2015 | C | 33,334 | $18.38 | A | 156,927 | D | |
| common sharesF1 | Nov 11, 2015 | S | 33,334 | $39.4161 | D | 123,593 | D | |
| common sharesF1 | Nov 9, 2015 | S | 25,000 | $39.2398 | D | 98,593 | D | |
| common sharesF1 | Nov 9, 2015 | S | 2,500 | $39.2502 | D | 7,550 | I | by "Pamela Gelfond Trust" |
| common sharesF1 | Nov 9, 2015 | S | 2,500 | $39.2494 | D | 7,550 | I | by "Claudia Gelfond Trust" |
| common shares (opening balance) | holding | — | — | — | 10,050 | I | by "Pamela Gelfond Trust" | |
| common shares (opening balance) | holding | — | — | — | 10,050 | I | by "Claudia Gelfond Trust" |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| stock options (to buy)F1,F2 | $18.38 | Nov 9, 2015 | C | 33,333 | D | Dec 31, 2013 | Dec 31, 2021 | common shares | 33,333 | 66,667 | D |
| stock options (to buy)F1,F2 | $18.38 | Nov 10, 2015 | C | 33,333 | D | Dec 31, 2013 | Dec 31, 2021 | common shares | 33,333 | 33,334 | D |
| stock options (to buy)F1,F2 | $18.38 | Nov 11, 2015 | C | 33,334 | D | Dec 31, 2013 | Dec 31, 2021 | common shares | 33,334 | 0 | D |
Explanation of responses
- F1Stock options were exercised and common shares sold pursuant to Rule 10b5-1 Sales Plan adopted on August 14, 2015. Mr. Gelfond's 10b5-1 Sales Plan is scheduled to terminate on September 16, 2016.
- F2This represents the remaining balance of the options granted on the issue date, December 31, 2011, following this transaction. Mr. Gelfond's aggregate remaining outstanding option, RSU and long share balances following all transactions will be 1,677,648; 59,978 and 113,693 respectively.